James River Group trades as part of the property and casualty insurance industry and is part of the financial services sector. The company CEO is Robert P. Myron. James River Group owns and operates a group of specialty insurance and reinsurance companies founded by members of its management team. It is organized for the purpose of acquiring and managing insurance and reinsurance entities.
Previous Intraday Performance:
The JRVR shares had a previous change of -1.01% which opened at 46.62 and closed at 46.08. It moved to an intraday high of 46.72 and a low of 46.00.
Over the last five trading days, JRVR shares returned 1.09% and in the past 30 trading days it returned 9.85%. Over three months, it changed 15.63%. In one year it has changed 18.59% and within that year its 52 week high was 46.78 and its 52 week low was 34.08. JRVR stock is 35.22% above its 52 week low.
Our calculations result in a 200 day moving average of 39.51 and a 50 day moving average of 42.48. Right now, JRVR stock is trading 16.63% above its 200 day moving average.
The company has a market cap of $1.4b with 30.2m shares outstanding and a float of 28.9m shares. Trading volume was 288,378 shares and has experienced an average volume of 176,242 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is bad, highly speculative and an investor may want to avoid this stock.
The last annual reported EPS for James River Group was 2.11 which ended on 31st of December 2018, which according to the previous close, that is a PE of 21.84. Based on 2 analyst estimates, the consensus EPS for the next quarter is 0.60. The trailing twelve month EPS reported is 2.33 (trailing twelve month diluted EPS is 2.33).
Below was the last reported quarterly diluted earnings per share:
|1st||Qtr 2019||Reported 05-01-2019:||0.75|
|4th||Qtr 2018||Reported 02-21-2019:||0.38|
|3rd||Qtr 2018||Reported 11-07-2018:||0.64|
|2nd||Qtr 2018||Reported 08-01-2018:||0.56|
|1st||Qtr 2018||Reported 05-02-2018:||0.52|
Base on our calculations, the intrinsic value per share is 31.12, which means it might be overvalued by -48.06%.
The growth of the EPS is critical in understanding the current valuation of James River Group; it is typically displayed as a percentage and called the EPS growth rate, which at this time is hard to estimate, but revenue growth has been 2.10% over the last twelve months.
Indicators Also to Watch:
The beta was calculated to be 0.49.
SeekingAlpha: Intra-Cellular Therapies beats by $0.24
Based on last reported financials, the company’s return on assets is 2.40%, profit margin is 8.13%, price-to-sales is 1.59 and price-to-book is 1.86.
Company Score Card:
Results are out of six:
1 : Growth Expectations Result
4 : Financial Safety Result
3 : Past Performance Result
0 : Valuation Result
3 : Dividend Safety Result
2 : Overall Result